Worden, Francis http://orcid.org/0000-0002-6632-4951
Rajkovic-Hooley, Olivera
Reynolds, Neil
Milligan, Gary
Zhang, Jingchuan
Funding for this research was provided by:
Eisai Incorporated
Article History
Received: 31 August 2023
Accepted: 28 November 2023
First Online: 16 December 2023
Compliance with ethical standards
:
: F.W. receives research funding from Merck, CUE, Elevar Therapeutics, Eli Lilly, LOXO, and Advara, and received honoraria from Eisai Inc., Regeneron Pharmaceuticals Inc., Merck and Company Inc., Exelixis Inc., Coherus, Soligenix, and CUE. O.R.-H., N.R. and G.M. are employees of Adelphi Real World, which received funding from Eisai Inc. for conducting this research. J.Z. is an employee of Eisai Inc.
: The study was conducted according to the Health Insurance Portability and Accountability Act (HIPAA) guidelines and legislation [], and all patient data were anonymized prior to analyses. The study protocol was reviewed by a central Institutional Review Board and was granted waiver from obtaining patient consent given the study nature being retrospective analyses.